Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nrx Pharmaceuticals Inc
(NQ:
NRXP
)
2.080
+0.040 (+1.96%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
37,965
Open
2.110
Bid (Size)
2.010 (20)
Ask (Size)
2.150 (13)
Prev. Close
2.040
Today's Range
2.050 - 2.140
52wk Range
1.681 - 7.333
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
August 15, 2024
Via
Get News
Topics
Regulatory Compliance
Retirement
Exposures
Legal
Pension
Regulatory
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024
August 14, 2024
NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-58.32%
-58.32%
1 Month
-11.11%
-11.11%
3 Month
-45.69%
-45.69%
6 Month
-51.36%
-51.36%
1 Year
-34.98%
-34.98%
More News
Read More
Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
July 30, 2024
Via
Get News
Exposures
Product Safety
Accelerated Approval to Treat Bipolar Depression and Akathisia Could Yield Over $150 in Revenue Per Share; Planned HOPE Subsidiary Spinoff to Continue: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
July 29, 2024
Via
Get News
NRx Pharmaceuticals Highlights Breakthrough Oral Antidepressant’s Efficacy in Reducing Suicidality in Bipolar Depression at ASCP June 2024 Meeting: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
June 10, 2024
Via
Get News
Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: Nasdaq: NRXP
August 15, 2024
Via
PRLog
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
First Oral Antidepressant Clinically Demonstrated to Reduce Suicidality in Bipolar Depression with Data Supporting Accelerated Approval Process: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
May 28, 2024
Via
Get News
12 Health Care Stocks Moving In Thursday's Intraday Session
May 16, 2024
Via
Benzinga
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
May 08, 2024
Via
ACCESSWIRE
Final Clinical Trial Results Show Superior Safety and Efficacy for NRX-101; Plans to Seek Accelerated Approval for Bipolar Depression and Schizophrenia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
May 06, 2024
Via
Get News
12 Health Care Stocks Moving In Monday's Intraday Session
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 30, 2024
Via
Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
April 30, 2024
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
April 30, 2024
Via
Benzinga
InvestorNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M
April 22, 2024
Via
Investor Brand Network
Exposures
Product Safety
Nasdaq Down 0.5%; Lithium Americas Shares Slide
April 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 18, 2024
Via
Benzinga
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
April 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
Via
Benzinga
Why Is Bio-Path (BPTH) Stock Up 89% Today?
April 18, 2024
Via
InvestorPlace
Why Is AGBA Group (AGBA) Stock Up 149% Today?
April 18, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.